Baron Wealth Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$335K Sell
536
-88
-14% -$51.6K 0.09% 179
2026
Q2
$330K Sell
624
-4
-0.6% -$1.85K 0.09% 184
2026
Q1
$302K Sell
628
-14
-2% -$7.17K 0.09% 180
2025
Q4
$361K Sell
642
-120
-16% -$68.1K 0.11% 146
2025
Q3
$392K Hold
762
– – 0.13% 116
2025
Q2
$239K Sell
762
-166
-18% -$49.8K 0.08% 181
2025
Q1
$283K Sell
928
-189
-17% -$63.6K 0.12% 140
2024
Q4
$371K Sell
1,117
-70
-6% -$23.7K 0.17% 98
2024
Q3
$396K Sell
1,187
-1
-0.1% -$380 0.19% 86
2024
Q2
$489K Sell
1,188
-7
-0.6% -$2.77K 0.25% 60
2024
Q1
$483K Hold
1,195
– – 0.26% 60
2023
Q4
$366K Buy
+1,195
New +$323K 0.2% 76

Other funds holding MEDP

Baron Wealth Management's MEDP Position: Q3 2026 in Review

Baron Wealth Management reduced its Medpace (MEDP) stake by 14% in Q3 2026, selling an estimated $51.6K and leaving 536 shares worth $335K. The position accounts for 0.09% of the portfolio, ranked #179.

Baron Wealth Management first reported a position in MEDP in Q4 2023 and has held it in 12 quarters since. The position peaked at $489K in Q2 2024. 525 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Baron Wealth Management held 536 shares of Medpace worth $335K as of Q3 2026.
  • Baron Wealth Management sold 88 Medpace shares in Q3 2026, an estimated $51.6K.
  • Medpace made up 0.09% of Baron Wealth Management's portfolio in Q3 2026, its #179 holding.
  • Baron Wealth Management first reported a position in Medpace in Q4 2023 and has held it in 12 quarters since.
  • Baron Wealth Management's Medpace position peaked at $489K in Q2 2024.
  • 525 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Baron Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.